2g2w: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="2g2w" size="450" color="white" frame="true" align="right" spinBox="true" caption="2g2w, resolution 1.80Å" /> '''Crystal Structure of...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2g2w.gif|left|200px]]<br /><applet load="2g2w" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:2g2w.gif|left|200px]]<br /><applet load="2g2w" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="2g2w, resolution 1.80&Aring;" />
caption="2g2w, resolution 1.80&Aring;" />
'''Crystal Structure of the SHV D104K Beta-lactamase/Beta-lactamase inhibitor protein (BLIP) complex'''<br />
'''Crystal Structure of the SHV D104K Beta-lactamase/Beta-lactamase inhibitor protein (BLIP) complex'''<br />


==Overview==
==Overview==
Beta-lactamase inhibitor protein (BLIP) binds a variety of class A, beta-lactamases with affinities ranging from micromolar to picomolar., Whereas the TEM-1 and SHV-1 beta-lactamases are almost structurally, identical, BLIP binds TEM-1 approximately 1000-fold tighter than SHV-1., Determining the underlying source of this affinity difference is important, for understanding the molecular basis of beta-lactamase inhibition and, mechanisms of protein-protein interface specificity and affinity. Here we, present the 1.6A resolution crystal structure of SHV-1.BLIP. In addition, a point mutation was identified, SHV D104E, that increases SHV.BLIP, binding affinity from micromolar to nanomolar. Comparison of the, SHV-1.BLIP structure with the published TEM-1.BLIP structure suggests that, the increased volume of Glu-104 stabilizes a key binding loop in the, interface. Solution of the 1.8A SHV D104K.BLIP crystal structure, identifies a novel conformation in which this binding loop is removed from, the interface. Using these structural data, we evaluated the ability of, EGAD, a program developed for computational protein design, to calculate, changes in the stability of mutant beta-lactamase.BLIP complexes. Changes, in binding affinity were calculated within an error of 1.6 kcal/mol of the, experimental values for 112 mutations at the TEM-1.BLIP interface and, within an error of 2.2 kcal/mol for 24 mutations at the SHV-1.BLIP, interface. The reasonable success of EGAD in predicting changes in, interface stability is a promising step toward understanding the stability, of the beta-lactamase.BLIP complexes and computationally assisted design, of tight binding BLIP variants.
Beta-lactamase inhibitor protein (BLIP) binds a variety of class A beta-lactamases with affinities ranging from micromolar to picomolar. Whereas the TEM-1 and SHV-1 beta-lactamases are almost structurally identical, BLIP binds TEM-1 approximately 1000-fold tighter than SHV-1. Determining the underlying source of this affinity difference is important for understanding the molecular basis of beta-lactamase inhibition and mechanisms of protein-protein interface specificity and affinity. Here we present the 1.6A resolution crystal structure of SHV-1.BLIP. In addition, a point mutation was identified, SHV D104E, that increases SHV.BLIP binding affinity from micromolar to nanomolar. Comparison of the SHV-1.BLIP structure with the published TEM-1.BLIP structure suggests that the increased volume of Glu-104 stabilizes a key binding loop in the interface. Solution of the 1.8A SHV D104K.BLIP crystal structure identifies a novel conformation in which this binding loop is removed from the interface. Using these structural data, we evaluated the ability of EGAD, a program developed for computational protein design, to calculate changes in the stability of mutant beta-lactamase.BLIP complexes. Changes in binding affinity were calculated within an error of 1.6 kcal/mol of the experimental values for 112 mutations at the TEM-1.BLIP interface and within an error of 2.2 kcal/mol for 24 mutations at the SHV-1.BLIP interface. The reasonable success of EGAD in predicting changes in interface stability is a promising step toward understanding the stability of the beta-lactamase.BLIP complexes and computationally assisted design of tight binding BLIP variants.


==About this Structure==
==About this Structure==
2G2W is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Klebsiella_pneumoniae Klebsiella pneumoniae] and [http://en.wikipedia.org/wiki/Streptomyces_clavuligerus Streptomyces clavuligerus]. Active as [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2G2W OCA].  
2G2W is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Klebsiella_pneumoniae Klebsiella pneumoniae] and [http://en.wikipedia.org/wiki/Streptomyces_clavuligerus Streptomyces clavuligerus]. Active as [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2G2W OCA].  


==Reference==
==Reference==
Line 15: Line 15:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Streptomyces clavuligerus]]
[[Category: Streptomyces clavuligerus]]
[[Category: Berger, J.M.]]
[[Category: Berger, J M.]]
[[Category: Bethel, C.R.]]
[[Category: Bethel, C R.]]
[[Category: Bonomo, R.A.]]
[[Category: Bonomo, R A.]]
[[Category: Corbett, K.D.]]
[[Category: Corbett, K D.]]
[[Category: Handel, T.M.]]
[[Category: Handel, T M.]]
[[Category: Kirsch, J.F.]]
[[Category: Kirsch, J F.]]
[[Category: Reynolds, K.A.]]
[[Category: Reynolds, K A.]]
[[Category: Thomson, J.M.]]
[[Category: Thomson, J M.]]
[[Category: beta-lactamase]]
[[Category: beta-lactamase]]
[[Category: beta-lactamase inhibitor]]
[[Category: beta-lactamase inhibitor]]
Line 29: Line 29:
[[Category: shv]]
[[Category: shv]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 10:55:16 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:27:34 2008''